NASS 2019 Annual Meeting
Tweet
Sessions
Speakers
Exhibitors
Products
Press Releases
Floor Plan
Buzz
Speakers
Matthew
Smuck, MD
Matthew Smuck, MD
Board of Directors: Spine Intervention Society (None); Consulting: Consultant & expert witness - State Farm (F), Spine Biopharma (Future Compensation Expected); Grants: Relievant Medsystems (F, Paid directly to institution/employer), ReWalk (E, Paid directly to institution/employer); Private Investments: Vivametrica (15.00%); Scientific Advisory Board: BlueJay Mobile-Health (Stock options), NuSpine (Stock options); Stock Ownership: BlueJay Mobile-Health (<1%), NuSpine (<1%); Trips/Travel: Spine Intervention Society, Board of Directors (B, Travel Expenses).
Sessions :
Spine Intervention Society & North American Spine Society Joint Symposium: Evolution: How Our History Shapes the Future of Spine Interventions
Home
Sessions
Speakers
Exhibitors
Products
Press Releases
Floor Plan
Tweet
Login
|
Back to top
ChirpE